Skip to main content
. 2011 Jul;165(1):19–28. doi: 10.1111/j.1365-2249.2011.04392.x

Fig. 4.

Fig. 4

Effect of antibody treatment during the chronic challenge period on expression of T helper type 17 (Th17) cytokines. Levels of expression of mRNA for (a) interleukin (IL)-17A, (b) IL-17F and (c) IL-6 by CD4+ T cells, relative to hypoxanthine phosphoribosyltransferase (HPRT). Significant differences compared to naive animals shown as **P < 0·01 and ***P < 0·001, compared to control animals shown as ##P < 0·01.